[1] Wojciechowski VV, Calina D, Tsarouhas K, et al. A guide to acquired vitamin K coagulophathy diagnosis and treatment: the Russian perspective[J].Daru,2017,25(1):10.DOI:10.1186/s40199-017-0175-z.
[2] Card DJ, Gorska R, Harrington DJ. Laboratory assessment of vitamin K status[J].J Clin Pathol,2020,73(2):70-75.DOI:10.1136/jclinpath-2019-205997.
[3] Kodali S, Rajendran T, Richard IN, et al. Superwarfarin exposure: an important uncommon cause of painless bleeding[J].J Hematol,2019,8(4):155-159.DOI:10.14740/jh538.
[4] Rubinstein I, van Breemen R, Nosal DG, et al. Should cytochrome P450 inducers be used to accelerate clearance of brodifacoum from poisoned patients?[J].Drugs R D,2019,19(1):67-71.DOI:10.1007/s40268-019- 0261-4.
[5] Kelkar AH, Smith NA, Martial A, et al. An outbreak of synthetic cannabinoid-associated coagulopathy in illinois[J].N Engl J Med,2018,379(13):1216-1223.DOI:10.1056/NEJMoa1807652.
[6] Gungorer B. Risk factors associated with warfarin overdose and complications related to warfarin overdose in the emergency department[J].Drug Chem Toxicol,2022,45(4):1732-1738.DOI:10.1080/01480545.2020.1868493.
[7] Khatib R, Ludwikowska M, Witt DM, et al. Vitamin K for reversal of excessive vitamin K antagonist anticoagulation: a systematic review and meta-analysis[J].Blood Adv,2019,3(5):789-796.DOI:10.1182/bloodadvances.2018025163.
[8] Witt DM, Nieuwlaat R, Clark NP, et al. American Society of Hematology 2018 guidelines for management of venous thromboembolism: optimal management of anticoagulation therapy[J].Blood Adv,2018,2(22):3257- 3291.DOI:10.1182/bloodadvances.2018024893.
[9] 中华医学会心血管病学分会,中国老年学学会心脑血管病专业委员会. 华法林抗凝治疗的中国专家共识[J]. 中华内科杂志,2013,52(1):76-82.DOI:10.3760/cma.j.issn.0578- 1426.2013.01.027.
[10] 王乔宇,武明芬,柳鑫,等. 2021中国静脉血栓栓塞症防治抗凝药物的选用与药学监护指南[J]. 中国临床药理学杂志,2021,37(21):2999-3016.DOI:10.13699/j.cnki.1001-6821. 2021.21.032.
[11] Fahmi AM, Elewa H, El Jilany I. Warfarin dosing strategies evolution and its progress in the era of precision medicine, a narrative review[J].Int J Clin Pharm,2022,44(3):599-607.DOI:10.1007/s11096-022-01386-8.
[12] Guo C, Kuang Y, Zhou H, et al. Genotype-guided dosing of warfarin in Chinese adults: a multicenter randomized clinical trial[J]. Circ Genom Precis Med,2020,13(4):e002602.DOI:10.1161/CIRCGEN.119.002602.
[13] Chong YK, Mak TW. Superwarfarin (long-acting anticoagulant rodenticides) poisoning: from pathophysiology to laboratory-guided clinical management[J].Clin Biochem Rev,2019,40(4):175-185.DOI:10.33176/AACB-19-00029.
[14] Feinstein DL, Nosal DG, Ramanathan S, et al. Effects of vitamin K1 treatment on plasma concentrations of long-acting anticoagulant rodenticide enantiomers following inhalation of contaminated synthetic cannabinoids[J].Clin Toxicol (Phila),2020,58(7):716-724.DOI:10.1080/15563650.2019.1687903.
[15] Rubinstein I, Weinberg G, van Breemen R, et al. Treatment for long acting anticoagulant rodenticide poisoning - beyond INR monitoring?[J].Toxicol Commun,2018,2(1):59-61.DOI:10.1080/24734306.2018.1500152.
[16] Yip L, Stanton NV, Middleberg RA. Vitamin K1 treatment duration in patients with brodifacoum poisoning[J].N Engl J Med,2020,382(18):1764-1765.DOI:10.1056/NEJMc1916199.
[17] Arepally GM, Ortel TL. Bad weed: synthetic cannabinoid-associated coagulopathy[J].Blood,2019,133(9):902-905.DOI:10.1182/blood-2018-11-876839.
[18] Ng WY, Ching CK, Chong YK, et al. Retrospective study of the characteristics of anticoagulant-Type rodenticide poisoning in Hong Kong[J].J Med Toxicol,2018,14(3):218-228.DOI:10.1007/s13181-018-0660-x.
|